COMPARATIVE EVALUATION OF SALIVARY ESTRIOL AND PROGESTERONE LEVELS IN WOMEN WITH PRETERM LABOR AND NORMAL PREGNANCY

Main Article Content

Dr Renu Roy

Keywords

Preterm labour, Salivary estriol, Salivary progesterone, Pregnancy, ELISA, Hormonal changes.

Abstract

Preterm labour is a major obstetric complication and an important cause of neonatal morbidity and mortality. Estriol and progesterone play significant roles in maintaining pregnancy and regulating the onset of labour. Salivary estimation of these hormones offers a convenient, non-invasive approach for evaluating endocrine changes associated with preterm labour.


Aim: To determine the levels of salivary estriol and progesterone in women with preterm labour and normal pregnancy.


Material and Methods: A comparative observational study was designed involving 152 pregnant women divided into four groups, with 38 participants in each group: Group I, Group IIA, Group IIB and Group II. Demographic and obstetric characteristics, including maternal age, gravida status and gestational age, were evaluated. Salivary samples were collected under standardized conditions, and estriol and progesterone concentrations were estimated using enzyme-linked immunosorbent assay (ELISA). The results were compared using appropriate statistical methods, including one-way analysis of variance (ANOVA).


Results: The majority of participants belonged to the age group up to 25 years, and primigravida women constituted the largest proportion across all four groups. Regarding salivary progesterone, Group I demonstrated the highest mean concentration (3944.40 ± 635.56 pg/ml), followed by Group IIA (3812.98 ± 656.62 pg/ml), Group II (3772.30 ± 660.70 pg/ml) and Group IIB (3576.91 ± 773.86 pg/ml). The difference was not statistically significant (F = 1.879, p = 0.136). Salivary estriol concentrations were highest in Group IIA (3548.54 ± 633.69 pg/ml), followed by Group II (2680.53 ± 647.38 pg/ml), Group I (2647.74 ± 648.36 pg/ml) and Group IIB (2611.85 ± 969.76 pg/ml). The difference among groups was statistically significant (F = 14.222, p < 0.001).


Conclusion: Salivary estriol demonstrated significant differences among the four study groups, whereas salivary progesterone did not show statistically significant variation. These findings indicate the potential relevance of salivary estriol in investigating hormonal changes associated with preterm labour. Further studies are required to establish the clinical utility of these hormones as predictive biomarkers.

Abstract 0 | Pdf Downloads 0

References

Yadav R, Singh U. Study of changes in levels of salivary estriol and progesterone in preterm labor in comparison to normal pregnancy. Int J Reprod Contracept Obstet Gynecol. 2019;8(12):4660-7.
2. Darne J, McGarrigle HHG, Lachelin GCL. Saliva oestriol, oestradiol, oestrone and progesterone levels in pregnancy: spontaneous labour at term is preceded by a rise in the saliva oestriol:progesterone ratio. Br J Obstet Gynaecol. 1987;94(3):227-35.
3. Darne J, McGarrigle HHG, Lachelin GCL. Increased saliva oestriol to progesterone ratio before preterm delivery: a possible predictor for preterm labour? BMJ. 1987;294(6567):270-2.
4. Lachelin GCL, McGarrigle HHG, Seed PT, Briley A, Shennan AH, Poston L. Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery. BJOG. 2009;116(11):1515-9.
5. McGregor JA, Jackson GM, Lachelin GCL, Goodwin TM, Artal R, Hastings C, et al. Salivary estriol as risk assessment for preterm labor: a prospective trial. Am J Obstet Gynecol. 1995;173(4):1337-42.
6. Heine RP, McGregor JA, Goodwin TM, Artal R, Hayashi RH, Robertson PA, et al. Serial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol. 2000;96(4):490-7.
7. Klebanoff MA, Meis PJ, Dombrowski MP, Zhao Y, Moawad AH, Northen A, et al. Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo. Am J Obstet Gynecol. 2008;199(5):506.e1-7.
8. McGregor JA, Hastings C, Dullien V. A meta-analysis of salivary estriol (sE3) as a means to identify women at risk for preterm birth due to fetal-placental endocrine mechanisms. Prim Care Update Ob Gyns. 1998;5(4):179.
9. McGarrigle HHG, Lachelin GCL. Increasing saliva (free) estriol to progesterone ratio in late pregnancy: a role for estriol in initiating spontaneous onset of labour at term. BMJ. 1984;287:457-9.
10. Kundu N, Novak N, Petersen LP. Salivary unconjugated estriol levels in normal third trimester pregnancy: direct correlation with serum levels. Steroids. 1983;41:145-53.
11. Vining RF, McGinley R, Rice BV. Saliva estriol measurements: an alternative to the assay of serum unconjugated estriol in assessing fetoplacental function. J Clin Endocrinol Metab. 1983;56:454-60.
12. Choe JK, Khan-Dawood FS, Dawood MY. Progesterone and estradiol in the saliva and plasma during the menstrual cycle. Am J Obstet Gynecol. 1983;147:557-62.
13. Purba E. The salivary estriol level was higher in preterm delivery compared to that in preterm pregnancy. Indones J Obstet Gynecol. 2012;36(2):66-70.
14. Yadav R. Role of salivary estriol to progesterone ratio in prediction of preterm labour. Int J Med Sci Diagn Res. 2019;3(10).
15. Salivary progesterone as a biomarker for predicting preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2023.